MSF Corporate Partner, Denis Dufresne and Corporate Associate, Molly Carroll joined client David Mehalick, Chairman of Coeptis Therapeutics Holdings Inc. this morning to ring the Nasdaq bell and open the US Markets in celebration of Coeptis’ listing on Nasdaq. On October 31st, Coeptis Therapeutics, Inc. announced the closing of the business combination with Bullhorn Holdings Corp. When asked about the combination, […]